Premium
Serum folic acid concentrations in the U.S. population after the introduction of folic acid fortification
Author(s) -
Pfeiffer Christine M,
Fazili Zia,
KennedyStephenson Jocelyn
Publication year - 2009
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.23.1_supplement.335.3
Subject(s) - fortification , folic acid , medicine , population , endocrinology , chemistry , food science , environmental health
Knowing what the serum folic acid (FA) concentrations in the U.S. population post‐fortification are is of great interest because FA might have a dual modulatory effect in carcinogenesis and circulating levels of FA in serum have been associated with reduced natural killer cell cytotoxicity in postmenopausal women. As part of a method comparison study, we analyzed 232 serum samples from NHANES 1999‐2004 (convenience set) for folate species by LC‐MS/MS. The distribution of FA concentrations was right‐skewed, with ~30% and 5% of the samples having levels >10 and >100 nmol/L, respectively. Median FA concentrations (nmol/L) were dependent on the length of fasting (29.0 at ≤3 h; 1.72 at 4‐6 h; 0.98 at 7‐12 h; 0.83 at >12 h), the use of FA‐containing supplements during the past month (4.90 for users; 0.63 for non‐users), and the use of a dietary supplement since starting the fasting for the blood draw (14.8 for users; 1.0 for non‐users). Fifteen percent of the FA variability was explained by these variables in a regression model. Subjects who fasted >3h and used no supplement during the past month or during fasting, had a baseline FA concentration of 3.11 nmol/L. For =3h fasting, use of a supplement during the past month, or use of a supplement during fasting, 21.5, 16.8, and 16.0 nmol/L FA needs to be added, respectively. To better interpret "free" FA serum levels, it is important to understand its determinants.